Charles S. Berkman
2010 - Ligand Pharmaceuticals
In 2010, Charles S. Berkman earned a total compensation of $459.5K as Vice President and General Counsel at Ligand Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $70,276 |
|---|---|
| Option Awards | $109,360 |
| Salary | $247,450 |
| Stock Awards | $29,880 |
| Other | $2,534 |
| Total | $459,500 |
Berkman received $247.5K in salary, accounting for 54% of the total pay in 2010.
Berkman also received $70.3K in non-equity incentive plan, $109.4K in option awards, $29.9K in stock awards and $2.5K in other compensation.
Rankings
In 2010, Charles S. Berkman's compensation ranked 7,997th out of 10,439 executives tracked by ExecPay. In other words, Berkman earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,997 out of 10,439 | 23rd |
Division Manufacturing | 2,966 out of 3,838 | 23rd |
Major group Chemicals And Allied Products | 707 out of 921 | 23rd |
Industry group Drugs | 492 out of 680 | 28th |
Industry Pharmaceutical Preparations | 368 out of 481 | 24th |
Source: SEC filing on April 25, 2013.
Berkman's colleagues
We found two more compensation records of executives who worked with Charles S. Berkman at Ligand Pharmaceuticals in 2010.